Hydroxychloroquine Sulfate

• CAT Number: A000121
• CAS Number: 747-36-4
• Molecular Formula: C18H26ClN3O ? H2SO4
• Molecular Weight: 434.00
• Purity: ≥95%
• Target: Immunology/Inflammation
• Storage: -20°C
• IUPAC Name: 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid
• InChI: InChI=1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)
• InChIKey: JCBIVZZPXRZKTI-UHFFFAOYSA-N
• SMILES: CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O

Hydroxychloroquine Sulfate（Cat No.:A000121）is a widely used antimalarial and immunomodulatory drug. It works by interfering with parasite lysosomal activity and pH, effectively treating Plasmodium infections. Beyond malaria, it is commonly prescribed for autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus, where it modulates immune responses by inhibiting antigen processing and cytokine production. Hydroxychloroquine Sulfate has also been investigated for antiviral activity in certain infections. Known for its oral bioavailability and long-term safety, it remains a cornerstone treatment for various inflammatory and parasitic diseases.

Reference

1: McHenry AR, Wempe MF, Rice PJ. Stability of Extemporaneously Prepared
Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
Int J Pharm Compd. 2017 May-Jun;21(3):251-254. PubMed PMID: 28557788.

2: Fan HW, Ma ZX, Chen J, Yang XY, Cheng JL, Li YB. Pharmacokinetics and
Bioequivalence Study of Hydroxychloroquine Sulfate Tablets in Chinese Healthy
Volunteers by LC-MS/MS. Rheumatol Ther. 2015 Dec;2(2):183-195. Epub 2015 Jul 10.
PubMed PMID: 27747530; PubMed Central PMCID: PMC4883261.

3: Chen FY, Xue B, Wang H. [Analysis of the clinical efficacy of yiqi fumai
injection combined hydroxychloroquine sulfate tablet for treating Sjogren/’s
syndrome]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Dec;32(12):1621-3. Chinese.
PubMed PMID: 23469599.

4: Liu YM, Chen Q, Zhang MQ, Liu GY, Jia JY, Pu HH, Liu Y, Hu CY, Lu C, Wang W,
Cao WE, Song B, Song YX, Zhu JM, Yu C. A parallel design study to assess the
bioequivalence of generic and branded hydroxychloroquine sulfate tablets in
healthy volunteers. Arzneimittelforschung. 2012 Dec;62(12):644-9. doi:
10.1055/s-0032-1329962. Epub 2012 Nov 8. PubMed PMID: 23138518.

5: Chopra A, Saluja M, Tillu G, Venugopalan A, Narsimulu G, Handa R, Bichile L,
Raut A, Sarmukaddam S, Patwardhan B. Comparable efficacy of standardized Ayurveda
formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid
arthritis (RA): a randomized investigator-blind controlled study. Clin Rheumatol.
2012 Feb;31(2):259-69. doi: 10.1007/s10067-011-1809-z. Epub 2011 Jul 20. PubMed
PMID: 21773714.

6: Modi S, Rosen T. Micropapular cutaneous sarcoidosis: case series successfully
managed with hydroxychloroquine sulfate. Cutis. 2008 Apr;81(4):351-4. PubMed
PMID: 18491485.

7: James JA, Kim-Howard XR, Bruner BF, Jonsson MK, McClain MT, Arbuckle MR,
Walker C, Dennis GJ, Merrill JT, Harley JB. Hydroxychloroquine sulfate treatment
is associated with later onset of systemic lupus erythematosus. Lupus.
2007;16(6):401-9. PubMed PMID: 17664230.

8: Eisen D. Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus:
An open trial. J Am Acad Dermatol. 1993 Apr;28(4):609-12. PubMed PMID: 8463463.

9: Bernstein HN. Ocular safety of hydroxychloroquine sulfate (Plaquenil). South
Med J. 1992 Mar;85(3):274-9. Review. PubMed PMID: 1546352.

10: Canadian Hydroxychloroquine Study Group. A randomized study of the effect of
withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J
Med. 1991 Jan 17;324(3):150-4. PubMed PMID: 1984192.